Skip to main content
OpenTrials

Clinical trial condition

Leukemia, B-Cell

Explore clinical trials studying Leukemia, B-Cell. Study availability and eligibility vary by location and protocol.

1,389 public trials 159 recruiting studies
Refine in advanced search Browse all conditions

Leukemia, B-Cell trial results

Completed

Ublituximab in Combination With TGR-1202 +/- Ibrutinib or Bendamustine in Patients With B-cell Malignancies

NCT02006485

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations
  • TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
  • TG Therapeutics Investigational Trial Site Jonesboro, Arkansas, United States
  • TG Therapeutics Investigational Trial Site Duarte, California, United States
  • TG Therapeutics Investigational Trial Site Atlanta, Georgia, United States
View Trial Details
Completed

Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

NCT00105001

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, +173 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States
  • LDS Hospital Salt Lake City, Utah, United States
View Trial Details
Completed

A Safety and Efficacy Study of Obinutuzumab Alone or in Combination With Chemotherapy in Participants With Chronic Lymphocytic Leukemia

NCT01905943

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +14 more
Locations
  • Hospital Iturraspe Santa Fe, Argentina
  • Hospital Erasme; Neurologie Brussels, Belgium
  • Cliniques Universitaires St-Luc Brussels, Belgium
  • Jessa Zkh (Campus Virga Jesse) Hasselt, Belgium
View all 174 locations
View Trial Details
Completed

Subcutaneous Alemtuzumab Combined With Oral Dexamethasone, Followed by Alemtuzumab Maintenance or Allo-SCT in CLL With 17p- or Refractory to Fludarabine

NCT01392079

Conditions
Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia, +15 more
Locations
  • Hanuschkrankenhaus Wien Vienna, Austria
  • University Hospital Vienna, Austria
  • Centre Hospitalier de la Côte Basque Bayonne, France
  • Hopital Avicenne Bobigny, France
View all 38 locations
View Trial Details

Related conditions